Join

Compare · ILMN vs PMD

ILMN vs PMD

Side-by-side comparison of Illumina Inc. (ILMN) and Psychemedics Corporation (PMD): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both ILMN and PMD operate in Medical Specialities (Health Care), so they compete in similar markets.
  • ILMN is the larger of the two at $24.87B, about 622.5x PMD ($40.0M).
  • ILMN has hit the wire 24 times in the past 4 weeks while PMD has been quiet.
  • ILMN has more recent analyst coverage (25 ratings vs 0 for PMD).
MetricILMNPMD
Company
Illumina Inc.
Psychemedics Corporation
Price
$164.45+0.91%
$2.68-3.60%
Market cap
$24.87B
$40.0M
1M return
+29.84%
-
1Y return
+102.77%
-
Industry
Medical Specialities
Medical Specialities
Exchange
NASDAQ
NASDAQ
IPO
2000
News (4w)
24
0
Recent ratings
25
0
ILMN

Illumina Inc.

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. It has a collaboration agreement with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer. The company was incorporated in 1998 and is headquartered in San Diego, California.

PMD

Psychemedics Corporation

Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, PCP, amphetamines, opiates, synthetic cannabinoids, and benzodiazepines. Its testing results provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data that can show a pattern of individual drug use over a longer period-of-time. The company provides its services to employers for applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation was founded in 1986 and is headquartered in Acton, Massachusetts.

Latest ILMN

Latest PMD